Non‐ergot dopamine agonist therapy for Parkinson's disease in Japan: A claims database analysis

IF 0.4 Q4 CLINICAL NEUROLOGY Neurology and Clinical Neuroscience Pub Date : 2023-01-10 DOI:10.1111/ncn3.12689
K. Wada-isoe, Yoshio Tsuboi, Hiroyuki Kondo, Yoshitsugu Kojima, T. Takeshima, K. Iwasaki
{"title":"Non‐ergot dopamine agonist therapy for Parkinson's disease in Japan: A claims database analysis","authors":"K. Wada-isoe, Yoshio Tsuboi, Hiroyuki Kondo, Yoshitsugu Kojima, T. Takeshima, K. Iwasaki","doi":"10.1111/ncn3.12689","DOIUrl":null,"url":null,"abstract":"Levodopa monotherapy and combination therapy with non‐ergot dopamine agonists (DAs; pramipexole, ropinirole, and rotigotine) are commonly used in patients with Parkinson's disease (PD). Changes in prescription preferences for each DA were reported previously; however, information regarding the selection of individual DAs is insufficient.","PeriodicalId":19154,"journal":{"name":"Neurology and Clinical Neuroscience","volume":"11 1","pages":"63 - 71"},"PeriodicalIF":0.4000,"publicationDate":"2023-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology and Clinical Neuroscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/ncn3.12689","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Levodopa monotherapy and combination therapy with non‐ergot dopamine agonists (DAs; pramipexole, ropinirole, and rotigotine) are commonly used in patients with Parkinson's disease (PD). Changes in prescription preferences for each DA were reported previously; however, information regarding the selection of individual DAs is insufficient.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
日本帕金森病的非麦角多巴胺激动剂治疗:一项索赔数据库分析
左旋多巴单药及与非麦角多巴胺激动剂(DAs)联合治疗;普拉克索、罗匹尼罗和罗替戈汀)常用于帕金森病(PD)患者。以前曾报道过每种DA的处方偏好变化;然而,关于个别da的选择的信息是不足的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
76
期刊最新文献
Systemic association of myelin oligodendrocyte glycoprotein antibody disease: A systematic review of literature Reduction rate of anti‐acetylcholine receptor antibody titer levels is an early prognostic indicator for myasthenia gravis Focal 18F‐fluorodeoxyglucose uptake in spinal dural arteriovenous fistula: A report of two cases A rare presentation of unilateral posterior reversible encephalopathy syndrome following a trivial head trauma Efficacy and safety of modified Atkins diet therapy for drug‐resistant epilepsy in children and adults: A systematic review and meta‐analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1